Skip to content

Rapport Therapeutics, Inc. RAPP Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$2.98B+62.8%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$5.55B+116%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$8.97B+1,075%
Biohaven logo
BiohavenBHVN
$1.27B-48.1%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.08B+319%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$24.2M+10.7%
Net income-$19.9M+17.5%
EPS (diluted)-$0.42+38.2%

Balance sheet

See full
Cash & equivalents$78.1M+35.5%
Total debt$10.8M+37.8%
Total equity$471.5M+65.0%
Total assets$497.6M+64.7%

Cash flow

See full
Operating cash flow-$13.1M+35.5%
CapEx$86.0K-70.4%
Free cash flow-$13.1M+36.0%

Valuation

See full
Enterprise value$1.79B+352%

Returns & leverage

See full
Return on equity-28.3%
Debt / equity0.0×
Current ratio27.1×-3.9×

Where this comes from

Computed from the period-end share price: $1.5B.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s market capitalization?
Rapport Therapeutics, Inc. (RAPP) reported market capitalization of $1.5B in Q1 2026.
How has Rapport Therapeutics, Inc.'s market capitalization changed year-over-year?
Rapport Therapeutics, Inc.'s market capitalization increased by 308.5% year-over-year, from $366.06M to $1.5B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.